Oxidant Stress Stimulates Expression of the Human Peroxiredoxin 6 Gene by a Transcriptional Mechanism Involving an Antioxidant Response Element
Overview
Biology
General Medicine
Affiliations
Peroxiredoxin 6 (Prdx6) is a unique antioxidant enzyme that can reduce phospholipid and other hydroperoxides. A549 cells, a human lung-derived cell line, express both Prdx6 and Nrf2, a transcription factor that binds to antioxidant-response elements (AREs) and promotes expression of antioxidant genes. Treatment of A549 cells with 500 microM H(2)O(2) increased Prdx6 mRNA levels 2.5-fold, whereas treatment with 400 microM H(2)O(2) or 200 microM tert-butylhydroquinone (t-BHQ) triggered a corresponding 2.5-fold increase in reporter gene activity in A549 cells transfected with the pSEAP2:Basic vector (BD Bioscience), containing 1524 nucleotides of the human Prdx6 promoter region. Deletion of a consensus ARE sequence present between positions 357 and 349 before the start of transcription led to a striking decrease in both basal and H(2)O(2)- or t-BHQ-induced activation in A549 cells and H(2)O(2)-induced activation in primary rat alveolar type II cells. Cotransfection with Nrf2 stimulated the Prdx6 promoter in an ARE-dependent manner, whereas it was negatively regulated by Nrf3. siRNA targeting Nrf2 down-regulated reporter gene expression, whereas siRNA targeting the Nrf2 repressor, Keap1, up-regulated it. Binding of Nrf2 to the ARE sequence in chromatin was confirmed by PCR after chromatin immunoprecipitation. These data demonstrate that the ARE within the Prdx6 promoter is a key regulator of basal transcription of the Prdx6 gene and of its inducibility under conditions of oxidative stress.
Current Insights into the Role of UV Radiation-Induced Oxidative Stress in Melanoma Pathogenesis.
Gieniusz E, Skrzydlewska E, Luczaj W Int J Mol Sci. 2024; 25(21).
PMID: 39519202 PMC: 11546485. DOI: 10.3390/ijms252111651.
New insight into the CNC-bZIP member, NFE2L3, in human diseases.
Xiong G, Li J, Yao F, Yang F, Xiang Y Front Cell Dev Biol. 2024; 12:1430486.
PMID: 39149514 PMC: 11325725. DOI: 10.3389/fcell.2024.1430486.
Mayer C, Riera-Ponsati L, Kauppinen S, Klitgaard H, Erler J, Hansen S Front Pharmacol. 2024; 15:1437939.
PMID: 39119604 PMC: 11306042. DOI: 10.3389/fphar.2024.1437939.
Lagal D, Montes-Osuna A, Ortiz-Olivencia A, Arribas-Parejas C, Ortiz-Alcantara A, Pescuezo-Castillo C Antioxidants (Basel). 2024; 13(7).
PMID: 39061949 PMC: 11274330. DOI: 10.3390/antiox13070881.
Xiong M, Guo M, Huang D, Li J, Zhou Y Clin Respir J. 2023; 17(7):638-646.
PMID: 37329238 PMC: 10363838. DOI: 10.1111/crj.13648.